drug development

Verge Genomics Scores $32 Million for AI-Driven Drug Discovery
Verge Genomics Scores $32 Million for AI-Driven Drug Discovery
CP Wire
Verge Genomics
drug development
artificial intelligence
Flag link:
Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?
Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?
Motley Fool
Alzheimer's disease
clinical trials
Biogen
drug development
BAN2401
Flag link:
Keep Your Eyes on Healthcare's Odd Couple: AbbVie and Alphabet
Keep Your Eyes on Healthcare's Odd Couple: AbbVie and Alphabet
Motley Fool
AbbVie
Calico
Alphabet
age-related disease
cancer
drug development
Flag link:
Cellect, denovoMATRIX start stem cell research project
Cellect, denovoMATRIX start stem cell research project
Fierce Biotech
Cellect Biotechnology
TU Dresden
drug development
stem cells
denovoMATRIX
Flag link:
Herpes virus discoveries could lead to new drugs
Herpes virus discoveries could lead to new drugs
Pharmaforum
drug development
herpes virus
Flag link:
Drug Development For Neglected Diseases Has Stagnated
Drug Development For Neglected Diseases Has Stagnated
Forbes
drug development
neglected diseases
Flag link:
As drug resistance grows, combining antibiotics could turn up new treatments
As drug resistance grows, combining antibiotics could turn up new treatments
Stat
antibiotics
antibiotic resistance
drug development
Flag link:
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
Endpoints
Catalent
Juniper Pharmaceuticals
UK
M&A
drug development
Flag link:
The Human Genome Project: At the Root of a Healthcare Revolution
The Human Genome Project: At the Root of a Healthcare Revolution
Yahoo/Motley Fool
Human Genome Project
DNA sequencing
gene therapy
drug development
Flag link:
Sage Therapeutics’ chief scientist on discovering drugs and taking risks
Sage Therapeutics’ chief scientist on discovering drugs and taking risks
Drug Delivery Business News
SAGE Therapeutics
drug discovery
drug development
Flag link:
DIA18: CRISPR, AI, blockchain and the future of drug development
DIA18: CRISPR, AI, blockchain and the future of drug development
Biopharma Dive
Drug Information Association
artificial intelligence
blockchain
drug development
Flag link:
AbbVie shares rise on $1 bln investment in partnership with Alphabet-backed health company
AbbVie shares rise on $1 bln investment in partnership with Alphabet-backed health company
Marketwatch
AbbVie
Calico Life Sciences
Alphabet
drug development
Flag link:
Comparing vaccine incentives in the US and Europe
Comparing vaccine incentives in the US and Europe
Biopharma Dive
vaccines
drug development
United State
Europe
Flag link:
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
CP Wire
Arcus Biosciences
Infinity Pharmaceuticals
drug development
IPI-549
AB928
AB122
breast cancer
ovarian cancer
Flag link:
There Go Those Drug Companies Inventing New Diseases Again
There Go Those Drug Companies Inventing New Diseases Again
Forbes
drug development
Flag link:
Vertex doubles size of cystic fibrosis drug discovery site
Vertex doubles size of cystic fibrosis drug discovery site
Fierce Biotech
Vertex Pharmaceuticals
R&D
drug development
cystic fibrosis
Flag link:
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
In a Landscape of 'Me Too' Drug Development, What Spurs Radical Innovation?
Harvard Business Week
innovation
drug development
Flag link:
FDA Chief Proposes New Pricing Model and Cites New Guidelines to Spur Antibiotic Development
FDA Chief Proposes New Pricing Model and Cites New Guidelines to Spur Antibiotic Development
CP Wire
FDA
Scott Gottlieb
antibiotic resistance
drug development
bacteriophage
Flag link:
'Patient-focused' drug development guidance coming, FDA chief says
'Patient-focused' drug development guidance coming, FDA chief says
Biopharma Dive
FDA
patients
drug development
Scott Gottlieb
Flag link:
Pharma R&D Investments Moderating -- But Still High
Pharma R&D Investments Moderating -- But Still High
Forbes
R&D
drug development
Flag link:

Pages